Clinical Trial Update: UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the ongoing Phase 1/2 study of UCD19 CAR-T cell therapy in pediatric patients with B-cell acute lymphoblastic leukemia and B-ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• UCD19 CAR-T (CD19-directed CAR-T cell therapy)

Snippet

Sponsor: University of Colorado, Denver | Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma | Phase 1, Phase 2 | Status: RECRUITING